Alnylam Pharmaceuticals
ALNY
#581
Rank
S$46.82 B
Marketcap
$363.07
Share price
2.75%
Change (1 day)
64.67%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of June 2024 : S$5.31 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are S$5.31 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2024)

Total assets by year

Year Total assets Change
2023-12-31S$5.05 B6.39%
2022-12-31S$4.75 B-3.48%
2021-12-31S$4.92 B9.28%
2020-12-31S$4.50 B39.59%
2019-12-31S$3.22 B50.09%
2018-12-31S$2.15 B-19.36%
2017-12-31S$2.66 B45.98%
2016-12-31S$1.82 B-6.81%
2015-12-31S$1.96 B37.49%
2014-12-31S$1.42 B167.74%
2013-12-31S$0.53 B51.53%
2012-12-31S$0.35 B-3.69%
2011-12-31S$0.36 B-27.93%
2010-12-31S$0.50 B-25.04%
2009-12-31S$0.67 B-14.8%
2008-12-31S$0.79 B11.64%
2007-12-31S$0.71 B93.08%
2006-12-31S$0.36 B124.75%
2005-12-31S$0.16 B51.83%
2004-12-31S$0.10 B80.42%
2003-12-31S$59.77 M113.83%
2002-12-31S$27.95 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
S$1.17 B-77.96%๐Ÿ‡บ๐Ÿ‡ธ USA
S$47.83 B 800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.53 B-14.60%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.62 B-50.62%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.13 B-97.40%๐Ÿ‡บ๐Ÿ‡ธ USA
S$129.24 B 2,331.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$184.37 B 3,369.02%๐Ÿ‡ซ๐Ÿ‡ท France
S$54.79 B 930.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel